2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India
New Delhi: For blood cancer patients in India suffering from an advanced or relapsed form of the disease, another “living drug” has been cleared, nearly a year after the country’s apex drug regulator approved the first homegrown cutting edge immunotherapy, …